A Study of Azetukalner Versus Placebo in Major Depressive Disorder
This study is recruiting in the United States. It is testing azetukalner for depression.
Multiple locations, including Phoenix
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United States. It is testing azetukalner for depression.
Multiple locations, including PhoenixThis study is recruiting in the United States, in Finland, in Poland, .... It is testing azetukalner for depression.
Multiple locations, including DothanThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in Uganda. It focuses on Schizophrenia.
In UgandaThis study is recruiting in Argentina. It focuses on Anxiety.
In ArgentinaThis study is recruiting in Bosnia and Herzegovina. It focuses on Schizophrenia.
In Bosnia and HerzegovinaThis study is recruiting in Bosnia and Herzegovina. It focuses on Anxiety.
In Bosnia and HerzegovinaThis study is recruiting in Bosnia and Herzegovina. It focuses on Schizophrenia.
In Bosnia and HerzegovinaThis study is recruiting in Colombia. It focuses on Schizophrenia.
In ColombiaThis study is recruiting in Colombia. It focuses on Bipolarity.
In ColombiaThis study is recruiting in Colombia. It focuses on Schizophrenia.
In ColombiaThis study is recruiting in Pakistan. It focuses on Anxiety.
In Pakistan